• Explore /
  • Poster
  • / Phase 1 study of the liposomal formulation of eribulin (E7389-LF): Results from the advanced gastric cancer expansion cohort.

Phase 1 study of the liposomal formulation of eribulin (E7389-LF): Results from the advanced gastric cancer expansion cohort.

Abstract Video & Slides Poster

Authors

Kensei Yamaguchi

Kensei Yamaguchi

Department of Gastroenterological Chemotherapy, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan

Kensei Yamaguchi , Satoru Iwasa , Motohiro Hirao , Takashi Oshima , Kazuaki Harada , Yasuyoshi Sato , Akihito Kawazoe , Kan Yonemori , Kazuhiro Nishikawa , Nozomu Machida , Yoshito Komatsu , Takuya Suzuki , Shiori Okumura , Reiko Nagai , Takao Takase , Kohei Shitara

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Clinical Trial Registration Number

NCT03207672

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 4025)

DOI

10.1200/JCO.2021.39.15_suppl.4025

Abstract #

4025

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Talal El Zarif

First Author: Karim Amrane Sr.

First Author: Kohei Shitara

First Author: Ilya Tsimafeyeu